These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9800752)

  • 1. Oestrogen-receptor status in management of breast cancer in UK.
    Mander BJ; Heal K; Porushotham AD; Wishart GC
    Lancet; 1998 Jul; 352(9121):36-7. PubMed ID: 9800752
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intracystic papillary carcinoma of the breast: report of three cases].
    El mazghi A; Bouhafa T; Loukili K; El kacemi H; Lalya I; Kebdani T; Hassouni K
    Pan Afr Med J; 2014; 18():207. PubMed ID: 25419333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional estrogen receptors as biochemical marker for the detection of hormone-dependent breast cancer.
    Vij U; Murugesan K; Kapur BM; Sarin R; Dhawan IK; Farooq A
    J Surg Oncol; 1990 Jan; 43(1):13-8. PubMed ID: 2296189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical aspects of steroid receptor assays.
    Leake RE
    Med Lab Sci; 1984 Jul; 41(3):257-61. PubMed ID: 6482693
    [No Abstract]   [Full Text] [Related]  

  • 5. Breast cancer--from clinic to laboratory.
    Gillett CE; Happerfield LC
    Br J Biomed Sci; 1997 Mar; 54(1):47-56. PubMed ID: 9167307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and progesterone receptors in relation to tissue and plasma estrogens, in predicting hormone dependency in human breast cancer.
    Drafta D
    Endocrinologie; 1982; 20(2):143-4. PubMed ID: 7123137
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunohistochemical markers of hormone sensitivity of breast carcinoma].
    Simone G; Paradiso A
    Pathologica; 1992; 84(1094):11-4. PubMed ID: 1300527
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictors of hormone response for patients with ER-unknown breast tumours.
    Hug V; Thames H; Bentzen S
    Br J Cancer; 1989 Mar; 59(3):421-5. PubMed ID: 2930708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection and treatment of ductal carcinoma of the breast].
    Semiglazov VV; Tabagua TT; Matsko DE
    Vopr Onkol; 2011; 57(6):699-701. PubMed ID: 22416383
    [No Abstract]   [Full Text] [Related]  

  • 10. Systematic review on hormone receptor testing in breast cancer.
    Nofech-Mozes S; Vella ET; Dhesy-Thind S; Hagerty KL; Mangu PB; Temin S; Hanna WM
    Appl Immunohistochem Mol Morphol; 2012 May; 20(3):214-63. PubMed ID: 22505008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of oestrogen receptor-beta in invasive breast tumours].
    Péter I; Számel I; Péley G
    Magy Onkol; 2004; 48(1):63-9. PubMed ID: 15105898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor determination by monoclonal antibody in fine needle aspiration breast cancer cytologies: a marker of hormone response.
    Burton GV; Flowers JL; Cox EB; Leight GS; Dent GA; Geisinger KR; McCarty KS; McCarty KS
    Breast Cancer Res Treat; 1987 Dec; 10(3):287-91. PubMed ID: 3447647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer.
    Chen WY; Colditz GA
    Nat Clin Pract Oncol; 2007 Jul; 4(7):415-23. PubMed ID: 17597706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [pS2 protein and breast cancer].
    Torre EA; Fulco RA
    Minerva Ginecol; 1995 Dec; 47(12):553-6. PubMed ID: 8720977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone receptor assays and their value in breast cancer therapy.
    Gaffney EV; Sharmanov AT; Moody WE; Halpin DP; Blakemore WS; Elliott CB
    Cancer Biother; 1993; 8(1):17-28. PubMed ID: 7812344
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of the proliferative activity of breast cancer for prognosis and therapy].
    Pickartz H
    Z Arztl Fortbild (Jena); 1991 Oct; 85(20):993-4. PubMed ID: 1776291
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic value of estrogen receptor determinations in patients with breast cancer.
    Rich MA; Furmanski P; Brooks SC
    Cancer Res; 1978 Nov; 38(11 Pt 2):4296-8. PubMed ID: 698969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapy.
    Alkner S; Ehinger A; Bendahl PO; Rydén L; Fernö M
    Eur J Cancer; 2015 Nov; 51(16):2304-13. PubMed ID: 26243193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormone receptors and breast cancer prognosis].
    Saez S; Pichon MF
    Pathol Biol (Paris); 1983 Dec; 31(10):801-8. PubMed ID: 6366701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers.
    Ogawa Y; Hai E; Matsumoto K; Ikeda K; Tokunaga S; Nagahara H; Sakurai K; Inoue T; Nishiguchi Y
    Int J Clin Oncol; 2008 Oct; 13(5):431-5. PubMed ID: 18946753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.